
March/April




The cost-saving potential of specialty or disease-specific ACOs can be huge...but it is unclear whether these specialty services are more efficiently provided through their own ACO or as ancillary to the burgeoning primary care ACO marketplace.

Market Dynamics Change How Plans Manage Oral and Office-Administered Agents


As payment reform models continue to evolve, practitioners must determine which strategy makes the most sense for their practice. Although the idea behind bundled payments may be worth considering, there are some concerns that this system could causes disruptions in oncology practices.


Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
5 Expanded FDA Approvals From October
3
Trial Data Yield Risk-Based NRSTS Treatment Strategies
4
FDA Approves Pembrolizumab Plus Enfortumab Vedotin for MIBC
5



